Lucile Packard Children’s Hospital Stanford Continues to Rank Among Top Children’s Hospitals in the Nation

2023–24 U.S. News & World Report Best Children’s Hospitals annual survey ranks the top pediatric facilities in the country to help families with complex and rare conditions find the best medical care for their children STANFORD, Calif., June 21, 2023 /PRNewswire/ — Lucile Packard Children’s Hospital Stanford has once again been named the top children’s hospital … Read more

Nuvilab Awarded as 2023 Technology Pioneer by World Economic Forum

The World Economic Forum announces selection of the 100 most promising Technology Pioneers, companies that are tackling such issues as sustainability, climate change and healthcare. Nuvilab, the South Korean food-tech startup with the core technology that analyses food and nutrition intake with 3D scanning and AI implementation won its spot in the Centre for Health … Read more

U.S. News & World Report Names MemorialCare Miller Children’s & Women’s Hospital Long Beach Among Best in Nation for Pediatric Pulmonology and Lung Surgery

LONG BEACH, Calif., June 21, 2023 /PRNewswire/ — MemorialCare Miller Children’s & Women’s Hospital Long Beach has been nationally ranked #40 as a 2023-2024 Best Hospital for Pediatric Pulmonology and Lung Surgery, according to the U.S. News & World Report. Miller Children’s & Women’s Hospital was also ranked among the top 10 regionally in the state … Read more

Lucile Packard Children’s Hospital Stanford sigue figurando entre los mejores hospitales infantiles del país

La encuesta anual 2023-24 de los mejores hospitales infantiles realizada por U.S. News & World Report clasifica los mejores centros pediátricos del país para ayudar a las familias con enfermedades complejas y poco comunes a encontrar la mejor atención médica para sus hijos STANFORD, California, 21 de junio de 2023 /PRNewswire-HISPANIC PR WIRE/ — Lucile … Read more

CymaBay Therapeutics Presents Data Showing Seladelpar Treatment in Primary Biliary Cholangitis (PBC) Correlates with Alleviation of Self-Reported Pruritus and Reduction in Serum IL-31 Levels

Additional data presented at The International Liver Congress™ 2023 show clinical risk factors for PBC disease progression present in a broader population of UDCA-treated PBC patients Preclinical data points to need for the study of novel pathways mediated by seladelpar and their role in reducing fibrosis NEWARK, Calif., June 21, 2023 /PRNewswire/ — CymaBay Therapeutics, … Read more

UNION therapeutics announces positive topline results from the OSIRIS investigator-initiated proof-of-concept study of oral orismilast in patients with hidradenitis suppurativa

Study demonstrates clinically relevant improvements in patients with hidradenitis suppurativa (HS) receiving 16 weeks of treatment with oral orismilast Study supports the dose-finding results from the recent IASOS Phase 2b study of oral orismilast in psoriasis Orismilast has been granted a Fast Track designation by the FDA for HS, and UNION plans to seek regulatory … Read more

Novo Holdings to acquire Ellab

COPENHAGEN, Denmark, June 21, 2023 /PRNewswire/ — Novo Holdings A/S, a leading global life sciences investor, today announced that it has agreed to acquire Ellab from EQT. Headquartered in Hillerød, Denmark, Ellab (“Ellab”) provides validation and monitoring solutions and services for biotech and pharmaceutical processes. Its solutions and services measure and document parameters such as temperature, … Read more

UNION therapeutics announces positive topline results from the OSIRIS investigator-initiated proof-of-concept study of oral orismilast in patients with hidradenitis suppurativa USA – English USA – English

Study demonstrates clinically relevant improvements in patients with hidradenitis suppurativa (HS) receiving 16 weeks of treatment with oral orismilast Study supports the dose-finding results from the recent IASOS Phase 2b study of oral orismilast in psoriasis Orismilast has been granted a Fast Track designation by the FDA for HS, and UNION plans to seek regulatory … Read more

Interius BioTherapeutics Highlights Strong Preclinical Data Supporting In Vivo Chimeric Antigen Receptor (CAR) Vector Evaluation in Clinic

Lead candidate demonstrates specificity, biologic activity and a favorable safety profile in extensive mouse and non-human primate models Upcoming company presentations at Cellicon Valley ’23 and In Vivo Engineering of Therapeutic Cells Summit PHILADELPHIA, June 21, 2023 /PRNewswire/ — Interius BioTherapeutics, a leading developer of in vivo cell-specific genetic medicine therapeutics, today announced the presentation of compelling … Read more

U.S. News Announces the 2023-2024 Best Children’s Hospitals

Cincinnati Children’s Hospital Medical Center moves to No. 1 overall WASHINGTON, June 21, 2023 /PRNewswire/ — U.S. News & World Report, the global authority in hospital rankings and consumer advice, today announced the 2023-2024 Best Children’s Hospitals rankings, designed to assist parents of children with rare or life-threatening illnesses and their doctors in choosing the right hospital … Read more